Aim Bulletin
Helium One upbeat on analysis over Balangida
Tanzania-focussed helium explorer Helium One Global has completed the analysis of its proprietary high-resolution Falcon airborne gravity gradiometry (AGG) and aeromagnetic data over the Balangida Rift Basin, it announced on Monday.
Bidstack expands deal with 'leading' global game publisher
In-game marketing technology company Bidstack announced the expansion of its exclusive native in-game advertising partnership with an unnamed “leading, global AAA game publisher” on Monday, with the addition of two mobile titles.
Fulcrum agrees £6m convertible loan with major shareholders
Fulcrum Utility Services has entered into an arrangement with Bayford & Co and funds managed by Harwood Capital Management, it announced on Monday, for funding of up to £6m through a convertible loan.
Journeo wins £0.7m bus stop display order
Information systems and transport technical services provider Journeo has received a £0. 7m purchase order for the supply and support of its advanced displays technology, it announced on Monday, from a Northern transport partnership.
Fusion Antibodies confident after 'challenging' first half
Contract research organisation Fusion Antibodies reported first-half revenues of £1. 9m on Monday, down from £2. 4m year-on-year.
Bigblu buying Australian satellite operation for £3m
Australasia and Nordics-focussed connectivity specialist Bigblu Broadband announced on Monday that its wholly-owned Australian business, SkyMesh, has conditionally completed the acquisition of the satellite operations of Harbour ISP, a subsidiary of Australia’s Uniti Group.
Agronomics invests another $3.5m in Liberation Labs
Cellular agriculture investor Agronomics announced on Monday that, further its announcement on 20 October, it has invested an additional $3. 5m in the $20m seed round of Liberation Labs - a “precision” fermentation contract manufacturer.
MaxCyte inks deal with South Korea's Curamys
Cell engineering technology company MaxCyte announced a strategic platform licence with South Korea-based biotechnology specialist Curamys on Monday, which develops cell and gene therapies using cell fusion technology to treat rare intractable diseases, including Duchenne muscular dystrophy and amyotrophic lateral sclerosis.
Serica production in-line as it seeks tax clarity
UK North Sea-focussed upstream oil and gas company Serica Energy updated the market on its recent operations on Monday, reporting that the North Eigg exploration well ‘3/24c-6B’ had been drilled to a total depth of 16,728 feet in the Jurassic Heather formation.
Equals Group FY results seen ahead of current market expectations
IT service management company Equals Group said on Monday that its full-year results were now on track to come in ahead of current market expectations.